Case Report

Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review

Table 1

Literature review.

Reference (first author)AgeSexSystemic involvementTherapyOutcome

Lopez-Estebaranz, 1993 [4]18 yMLiver dysfunctionSS, ATB, MTX, and PUVA Cure
Fink-Puches, 1994 [5]16 yM(—)SS, ATB, and MTXCure
Romaní, 1998 [6]12 yF(—) ATB, MTX, and PUVACure
Ito, 2003 [7]12 yMAnemia, abdominal pain, and lymphadenopathySS, MTXCure
Tsianakas, 2005 [8]9 yM(—)SS, ATB, and MTXCure
Herron, 2005 [9]8 yFSepsis, DIG, ARDS, and gastrointestinal hemorrhageSS, MTX, ATB, and cyclosporineCure
Pyrpasopoulou, 2007 [10]17 yFSepsis, anemia, and diarrheaSS, ATB, IVIG, acyclovir, and MTXCure
Helbling, 2009 [11]17 yMLymphadenopathyATB, MTX
Zhang, 2010 [12]12 yMPulmonary involvementSS, ATB, and MTXCure
Kaufman, 2012 [13]21 mFLaryngeal edemaSS, MTXCure
Kaufman, 2012 [13]22 mF(—)SS, ATB, acyclovir, and MTX
Perrin, 2012 [14]34 mM(—)SS, ATB, acyclovir, dapsone, IVIG, and MTXCure
Lin, 2012 [15]11 yMFever, arthritis, fatigueSS, MTXCure
Rosman, 2013 [16]11 y MCentral nervous system vasculitisSS, ATB, MTX, and cyclophosphamideCure
Our patient11 yMLiver dysfunctionSS, ATB, and MTXCure

F: female, M: male, y: year, m: month, SS: systemic steroid, ATB: antibiotic, MTX: methotrexate, IVIG: intravenous immunoglobulin, and PUVA: psoralen UVA.